下丘脑食欲素在药物成瘾中的作用

下丘脑是调控自然奖赏的重要脑区,它能特异性地表达一种神经肽——食欲素(orexin),这种神经肽在药物奖赏中的作用受到广泛关注。在成瘾研究中,发现不同脑区中的食欲素神经元对奖赏和动机行为的调节作用是不相同的:围穹窿区(PFA)和背内侧下丘脑区(DMH)的食欲素神经元主要参与激活应激系统,而外侧下丘脑(LH)的食欲素神经元主要通过激活与奖赏学习相关的大脑环路参与奖赏行为的调控。提示食欲素系统可在延长戒断防止复吸发生中成为新的研究目标,食欲素受体可以作为治疗药物成瘾的一种新的治疗靶标。     

食欲素神经肽在应激过程中的作用

食欲素因其在调节能量代谢、睡眠和唤醒等生理功能中的作用而备受关注.近年来研究逐渐发现,食欲素参与应激和奖赏过程的调节,特别是其在药物成瘾过程中的作用是目前的研究热点.主要介绍食欲素系统与应激相关系统之间的神经联系,阐述了其在应激相关的生理、神经内分泌与行为反应中的作用.并进一步介绍了食欲素系统在应激诱发药物成瘾复吸过程中的作用.食欲素对应激反应的调控作用具有相对特异性,受应激的种类、其他应激相关神经递质系统及食欲素神经元的投射通路等多种因素影响.     

食欲素系统与物质成瘾

成瘾是物质使用障碍的严重形式,是一种以奖励、动机、记忆等功能紊乱为特征的慢性脑部疾病,给个人和社会造成严重后果.食欲素是下丘脑食欲素能神经元分泌的一类神经肽,不仅参与多种神经系统的正常生理功能,也与多种神经系统疾病的发生有着密切关系.其中,食欲素在物质成瘾中的作用研究正逐步得到重视,现已证实食欲素在多种物质成瘾中发挥着...     

下丘脑黑皮质素及中脑多巴胺系统对奖赏行为的调控

动机行为受生理需求相关神经环路的调控,包括管理摄食、能量代谢等内在动机行为的下丘脑黑皮质素(melanocortin, MC)系统和负责奖赏环路的中脑多巴胺(dopamine, DA)系统. MC系统中前阿黑皮素原(proopiomelanocortin,POMC)神经元与刺豚鼠相关蛋白(agouti-related protein,AgRP)神经元合成与分泌的递质及神经肽协同完成了对摄食等动机行为的调控,且DA系统通过调节奖赏环路参与摄食等动机行为的发生过程.此外,高强度的激活DA系统是成瘾性药物的共同特征,当DA系统激活与用药行为反复关联后,部分使用者进入药物成瘾状态,他们表现出强迫性的觅药动机.已有研究提示,药物成瘾的过程可能是药物导致动机行为调控中枢发生适应性改变的过程,这个变化反之促发了强迫性觅药行为的形成.本文将从下丘脑黑皮质素系统两种主要的神经元——POMC神经元和AgRP神经元——在对于摄食和用药相关的奖赏行为调控作用入手,分析它们与DA系统的相互作用模式,论述下丘脑黑皮质素系统的功能失调与药物成瘾的关系.     

药物滥用与神经元结构可塑性改变的关系

药物成瘾所导致的行为和生理方面的长时程改变可能与相关脑区突触连接的重构有关。安非他命、可卡因、吗啡和尼古丁滥用时,精神依赖和奖赏效应相关脑区神经元的树突和树突棘的结构发生改变,这反映药物滥用致相关神经回路突触连接方式的改变。这种改变足长时程的、脑区特异性的,是多种因素调节的结果。     

针刺对术后胃肠功能紊乱大鼠胃肠传输功能及脑肠肽的影响

摘要 目的：探讨针刺三里穴、中脘对大鼠胃大部切除术后胃肠传输功能恢复的影响及可能的作用机制。方法：将60只 SD 大鼠随机分为空白组、模型组和针刺组,每组 20 只。造模成功后第3天开始,针刺组进行针刺足三里、中脘,连续治疗14天。于末次针刺结束后,各组记录进食量、体重等;后各组禁食24 h后进行胃残留率和小肠推进率测定,腹主动脉取血测定胃泌素、胃动素、食欲素A及食欲素1型受体。结果：造模前,三组大鼠体重和进食量差异无统计学意义,P>0.05。造模后3天,模型组及针刺组体重和进食量低于空白组,差异有统计学意义,P<0.05。针刺干预后,模型组体重和进食量低于空白组和针刺组,差异有统计学意义,P<0.05。针刺干预后,针刺组大鼠胃残留率、小肠推进率、胃泌素、胃动素、食欲素A及食欲素1型受体高于模型组,差异有统计学意义,P<0.05;模型组胃残留率、小肠推进率、胃泌素、胃动素、食欲素A及食欲素1型受体低于空白组,差异有统计学意义,P<0.05;针刺组与空白组胃残留率、小肠推进率、胃泌素、胃动素、食欲素A及食欲素1型受体差异无统计学意义,P>0.05。结论：针刺胃大部切除术后大鼠足三里穴、中脘穴,改善胃排空和小肠推进功能,促进术后胃肠功能的恢复,其作用机制可能为改变脑肠肽代谢,增加食欲素A水平,激活食欲素1型受体,促进胃泌素、胃动素分泌。     

miRNAs与药物成瘾

药物成瘾是一种慢性复发性脑病,主要表现为不可控制的对药物持续渴求和戒断后的高复吸。目前观点认为,成瘾是中脑腹侧被盖（ventral tegmental area,VTA）到伏隔核（nucleus accumbens,NAc）脑区多巴胺能奖赏通路中神经可塑性发生改变而导致的一种神经精神疾病。基因表达变化在神经可塑性中发挥着重要作用,但成瘾药物导致相关脑区结构和功能改变的机制还不甚清楚。微小RNAs（microRNAs,miRNAs）是一类非编码RNA,主要通过结合靶基因mRNA 3′非翻译区（3′untranslated region,3′UTR）,在转录后水平阻断其翻译成蛋白质或触发其不稳定而降解。越来越多的研究证实,miRNAs参与调节成瘾相关神经可塑性的变化。本文较系统地阐述miRNAs在药物成瘾中的作用研究进展,将为深入阐明药物成瘾的机制以及药物成瘾临床有效干预和诊治提供新思路。     

间断低氧对大鼠下丘脑超微结构及前增食欲素水平的影响

目的探讨睡眠中间断低氧对大鼠下丘脑前增食欲素及受体水平的影响以及下丘脑超微结构的变化。方法大鼠分成对照组、间断低氧组和持续低氧组,分别给予吸入空气,持续低氧和间断低氧气体,并在实验开始后1d、3d、1w和4w应用RT-PCR方法测定大鼠下丘脑前增食欲素及受体水平,分析其间的变化关系,电镜观察下丘脑的超微结构变化。结果与对照组和持续低氧组比较,间断低氧4w后大鼠下丘脑前增食欲素mRNA水平明显降低,受体水平升高,但在持续低氧和对照组之间无明显差异。在低氧后1d、3d、7d后大鼠下丘脑前增食欲素mRNA降低,受体水平升高,在4w后,持续低氧组则接近正常。急性持续低氧大鼠超微结构变化更严重,而慢性间断低氧变化更持久。结论慢性间断低氧可以引起下丘脑前增食欲素下降及受体水平升高,急性持续低氧也可引起上述变化,而慢性持续低氧未引起增食欲素改变;慢性间断低氧大鼠下丘脑超微结构表现为严重而持久的变化。     

可卡因环境相关奖赏记忆提取激活伏隔核中央核和杏仁核基底外侧核神经元

奖赏刺激和伴药环境之间的强烈关联记忆,使得成瘾者在戒除药物数月或数年后暴露于类似环境即可诱发复吸。研究成瘾记忆的神经生物学基础有重要意义。本研究以可卡因条件位置偏爱(conditioned place preference,CPP)实验为行为学模型模拟分析药物与环境之间关联的建立。c-Fos、Zif268是常用的反映神经元活动增加的即早基因标记物。本文旨在通过采用免疫组织荧光染色方法,对可卡因环境相关的奖赏记忆提取后小鼠各脑区c-Fos、Zif268表达进行定量,比较分析它们的表达差异,以此来观察环境相关奖赏记忆提取时不同脑区神经元的激活情况。C57BL/6小鼠分为三组:生理盐水提取组、可卡因环境相关奖赏记忆提取组以及可卡因未提取组。后两组均接受CPP训练(一侧为伴可卡因侧,另一侧为伴生理盐水侧),训练结束后可卡因环境相关奖赏记忆提取组提取相关记忆,可卡因未提取组不提取。生理盐水提取组在放入CPP箱两侧前均腹腔注射生理盐水。结果显示,在药物成瘾相关脑区伏隔核核部,可卡因环境相关奖赏记忆提取组c-Fos、Zif268蛋白表达量显著高于生理盐水提取组。可卡因环境相关奖赏记忆提取组杏仁核基底外侧核Zif268蛋白表达量显著高于生理盐水提取组。在中脑边缘多巴胺系统的其他相关脑区如前额叶皮层、海马等,各组间c-Fos、Zif268蛋白表达量并未观察到明显的差异。以上结果表明伏隔核中央核和杏仁核基底外侧核在可卡因环境相关奖赏记忆提取过程中被激活,这提示伏隔核中央核和杏仁核基底外侧核脑区内激活的神经元是可卡因环境相关奖赏记忆的重要神经基础,为进一步解析药物成瘾记忆机制打下了基础。     

前边缘皮质生长激素抑制素神经元在吗啡引起的行为学改变中的作用

药物成瘾是一种由药物滥用所引起的慢性、复发性的精神疾病,主要特征是不计后果的强迫性用药。药物成瘾涉及多个脑区的神经可塑性改变。前边缘皮质(prelimbic cortex, PrL)是背内侧前额叶皮质的主要区域,有大量的锥体神经元,其兴奋性神经投射可以促进可卡因觅药行为。PrL还存在少量GABA能中间神经元,对PrL的兴奋性神经元功能、信息整合和传递起到重要的调控作用,而这一部分神经元在药物成瘾过程中的作用并不清楚。小清蛋白(parvalbumin, PV)和生长激素抑制素(somatostatin, SST)神经元是前额叶皮质中分布广泛的两类主要的抑制性GABA能中间神经元。本研究利用PV-Cre和SSTCre的转基因小鼠,结合化学遗传学的方法探究PrL中间神经元在吗啡引起的行为学改变中的作用。结果显示,特异性抑制PrL脑区SST神经元可以显著增加小鼠的焦虑水平,但不影响小鼠的运动能力;抑制PrL脑区SST神经元降低小鼠吗啡诱导的活动性增强及条件位置偏爱;而抑制PrL脑区PV神经元则对小鼠的运动能力、焦虑水平及吗啡引起的行为学改变均没有显著影响。本研究通过对PrL脑区PV及SST中间神经元在吗啡诱导的行为学改变中作用的研究,为成瘾药物作用的细胞及神经基础提供了依据。     

Orexin receptors: Multi-functional therapeutic targets for sleeping disorders,eating disorders,drug addiction,cancers and other physiological disorders

The orexin peptides (orexin A, orexin B) and their receptors (orexin receptor type 1, orexin receptor type 2) are involved in multiple physiological processes such as the regulation of sleep/wakefulness state, energy homeostasis and reward seeking. A result of this has been the development of small-molecule orexin receptor antagonists as novel therapies for the treatment of insomnia and drug addiction. Increased levels of signaling via the orexin peptide/receptor system may protect against obesity, while somewhat unexpectedly, orexins acting at orexin receptors induce dramatic apoptosis resulting in the significant reduction of cell growth in various cancer cell lines. Meanwhile, the orexin peptide/receptor system is also involved in cardiovascular modulation, neuroendocrine and reproduction regulation. This review summarizes the latest developments in deciphering the biology of orexin signaling as well as efforts to manipulate orexin signaling pharmacologically.     

Structure and functions of the brain orexin-containing neurons

The results of investigations of the new discovered brain orexin neurons, their chemical structure, localization and functions are reviewed. The following data are described: the specifics of orexins mRNA, orexins A and B and their receptors; connections between orexin neurons and neurons from different structures of the brain and spinal cord and the participation of the orexin neuron system in the functional regulation.     

Orexin 受体拮抗剂：治疗失眠的新途径

Orexin 受体有2 种亚型,即orexin-1 受体和oerxin-2 受体,为下丘脑外侧神经元中的2 个G 蛋白偶联受体,其内源性配体分别为orexin-A 和-B。研究发现,动物或人的orexin 神经元损伤后会引起嗜睡症,且orexin 受体在调节睡眠- 觉醒周期方面发挥重要作用。因此,开发orexin 受体拮抗剂,成为改善睡眠和治疗失眠的一条新途径。简介orexin 及其受体,综述orexin 信号通路对睡眠- 觉醒的调控作用与机制以及orexin 受体拮抗剂的研究与开发。     

Expression of the orexin system in the porcine uterus,conceptus and trophoblast during early pregnancy

Orexin A and B are hypothalamic peptides derived from the prepro-orexin (PPO) precursor. Orexins stimulate food intake and arousal. Those peptides bind and activate two G protein-coupled receptors: orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). Numerous authors have suggested that orexins play an important role in the regulation of the reproductive functions. The objective of the present study was to analyse the presence of and changes in the gene and protein expression pattern of the orexin system in the porcine uterus, conceptus and trophoblast (chorioallantois) during early pregnancy. In the endometrium, the highest PPO and OX1R gene expression was detected on days 15 to 16 of gestation. The OX2R mRNA content in the endometrium was higher on days 10 to 11 and 15 to 16 than on days 12 to 13 and 27 to 28. In the trophoblasts, PPO gene expression was higher on days 30 to 32 than on days 27 to 28. The highest PPO protein content in the endometrium was noted on days 12 to 13. The highest OX1R protein content in the endometrium was detected on days 10 to 11, whereas OX2R protein on days 15 to 16. In the trophoblasts, PPO and OX1R protein levels were more pronounced on days 27 to 28 than on days 30 to 32, but OX2R expression was higher on days 30 to 32. The expression of PPO, OX1R and OX2R was different in the conceptuses and trophoblasts during early pregnancy. Local orexin production and the presence of the specific orexin receptors suggest that the orexin system may participate in the control of porcine reproductive functions by exerting endocrine and auto/paracrine effects on the uterus, conceptuses and trophoblasts during early pregnancy. This study provides the first evidence for the presence of orexins and their receptors in the uteri, conceptuses and trophoblasts in pigs during early pregnancy. The local orexin system is dependent on the stage of pregnancy.     

Metabolic state signalling through central hypocretin/orexin neurons

Hypothalamic neurons that produce the peptide transmitters hypocretins/orexins have attracted much recent attention. They provide direct and predominantly excitatory inputs to all major brain areas except the cerebellum, with the net effect of stimulating wakefulness and arousal. These inputs are essential for generating sustained wakefulness in mammals, and defects in hypocretin signalling result in narcolepsy. In addition, new roles for hypocretins/orexins are emerging in reward-seeking, learning, and memory. Recent studies also indicate that hypocretin/orexin neurons can alter their intrinsic electrical activity according to ambient fluctuations in the levels of nutrients and appetite-regulating hormones. These intriguing electrical responses are perhaps the strongest candidates to date for the elusive neural correlates of after-meal sleepiness and hunger-induced wakefulness. Hypocretin/orexin neurons may thus directly translate rises and falls in body energy levels into different states of consciousness.     

Inhibition of food intake by central injection of anti-orexin antibody in fasted rats

It has been shown that intracerebroventricular injection of synthetic orexins stimulated food intake in rats. This pharmacological evidence suggests that orexins may have a role for the central regulation of feeding. In the present study, we investigated the hypothesis of whether endogenous orexins indeed play a vital role in feeding behavior. An anti-orexin polyclonal antibody was used throughout the study. First, we examined the specificity of the antibody to orexin by Western blot analysis and immunohistochemistry. Next, the effects of central injection of the orexin antibody on food intake in 24-h-fasted rats were evaluated. Western blot analysis revealed that the orexin antibody detected synthetic orexin-A. Immunohistochemical study showed that orexin-positive neurons were identified only in the lateral hypothalamic area, in agreement with previous reports. Neither control antibody nor the orexin antibody preabsorbed with excess amount of orexin-A detected neurons, indicating that the orexin antibody is specific. Intracisternal but not intraperitoneal injection of the orexin antibody dose-dependently suppressed feeding. All these results suggest that immunoneutralization of endogenous orexins in the brain reduced food intake. In other words, we suggest that endogenous brain orexin may have a physiologically relevant action on feeding behavior.     

Receptors for oreksins: structure, localisation and activation mechanisms

The review concerns morpho-functional characteristics of orexin receptors. The data on their structure, signal transduction pathways, biological effects of orexin receptors 1 or 2 depending on association with different G-proteins are presented. Localisation of orexin receptors in various CNS structures as well as in peripheral organs mediates regulation of different physiological functions by orexins. Low concentration of orexins in peripheral blood and orexin-containing cells in ganglions and internal organs suggests a possibility to activate orexin-sensitive cells distantly, paracrinely or autocrinely. The data on effects of selective or non-selective orexin receptor antagonists is analysed.     

OX2R activation induces PKC-mediated ERK and CREB phosphorylation

Deficiencies in brain orexins and components of mitogen activated protein kinase (MAPK) signaling pathway have been reported in either human depression or animal model of depression. Brain administration of orexins affects behaviors toward improvement of depressive symptoms. However, the documentation of endogenous linkage between orexin receptor activation and MAPK signaling pathway remains to be insufficient. In this study, we report the effects of orexin 2 receptor (OX2R) activation on cell signaling in CHO cells over-expressing OX2R and in mouse hypothalamus cell line CLU172. Short-term extracellular signal-regulated kinase (ERK) phosphorylation and long-term cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) phosphorylation were subsequently observed in CHO cells that over-express OX2R while 20 min of ERK phosphorylation was significantly detected in mouse adult hypothalamus neuron cell line CLU172. Orexin A, which can also activate OX2R, mediated ERK phosphorylation was as the same as orexin B in CHO cells. A MAPK inhibitor eliminated ERK phosphorylation but not CREB phosphorylation in CHO cells. Also, ERK and CREB phosphorylation was not mediated by protein kinase A (PKA) or calmodulin kinase (CaMK). However, inhibition of protein kinase C (PKC) by GF 109203X eliminated the phosphorylation of ERK and CREB in CHO cells. A significant decrease in ERK and CREB phosphorylation was observed with 1 μM GF 109203X pre-treatment indicating that the conventional and novel isoforms of PKC are responsible for CREB phosphorylation after OX2R activation. In contrast, ERK phosphorylation induced by orexin B in CLU172 cells cannot be inhibited by 1 μM of protein kinase C inhibitor. From above observation we conclude that OX2R activation by orexin B induces ERK and CREB phosphorylation and orexin A played the same role as orexin B. Several isoforms of PKC may be involved in prolonged CREB phosphorylation. Orexin B induced ERK phosphorylation in mouse hypothalamus neuron cells differs from CHO cell line and cannot be inhibited by PKC inhibitor GF 109203X. And hypothalamus neuron cells may use different downsteam pathway for orexin B induced ERK phosphorylation. This result supports findings that orexins might have anti-depressive roles.